SUMMARY: A serological comparison on gel-diffusion plates of purified preparations of factors I and I1 of the anthrax toxin obtained in vitro and in Wive indicated that all but one (factor I from in Witro sources) of these preparations contained at least two major serological components. At least three serological components were involved in the total system: A (associated with factor I activity); B (associated with factor I1 activity); C (not associated with toxic activity). These results indicated that no preparation of factor I1 of the anthrax toxin so far examined was immunologically homogeneous and that the serological connexion between factor I of the anthrax toxin (produced in wivo) and the protective factor produced in Witro (Smith, 1958) was due to a common component not associated with factor I activity. There was some evidence that the method of measuring immunogenicity in certain culture filtrates of BacilZus u n t h r d by serological precipitation (Thorne & Belton, 1957) is not generally applicable to all products of this organism.
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In the previous paper (Stanley, Sargeant & Smith, 1960) the purification of factors I and I1 of the anthrax toxin from the plasma of guinea-pigs dying of anthrax was described. The factor I preparation contained a small amount of guinea-pig plasma constituents and the factor I1 preparation was largely guinea-pig a-globulin. An immunogenic preparation from Badlu8 anthmcw was first produced in vitro in a defined medium by Wright, Hedberg & Slein (1954) and later in a partially-defined medium by Belton & Strange (1954) . Smith, Keppie & Stanley (1955) showed that this non-toxic preparation was serologically related to anthrax toxin; later Smith et aZ. (1956) showed that partially purified material (Strange & Belton, 1954) had factor I1 activity. Our colleagues Strange & Thorne (1958) carried this purification further and we have shown that their final product also has high factor I1 activity. Following the production of anthrax toxin in vitro by Harris-Smith, Smith & Keppie found that the other factor of the toxin was produced along with their protective preparation but was adsorbed on the glass filters used to obtain a sterile filtrate. This factor could be removed by eluting the filters with a buffer of high pH value. W e confirmed that in relation to the in vivo products the adsorbed factor was factor I of the toxin; we have now purified it by a process similar to that described for obtaining factor I from toxic guinea-pig plasma.
The preparations described above all appeared to form one main precipitation line in serological gel-diffusion plates when diffused separately at relatively high concentrations against anthrax antisera in the system used by Thorne & Belton (1957) Sargeant & Smith, 1958) . However, when the various preparations were examined more closely by diffusion a t high concentrations, by diffusion adjacent to one another, and by diffusion over greater distances with more acute angles between the planes of precipitation, it appeared that three of the four preparations were mixtures of major serological components. Some precipitation lines which appeared to be single in the simple system then appeared to be composite. The present paper describes the serological comparison of these different products and indicates which serological entities are associated with toxicity. These results have some bearing on any general application of the assay for immunogenicity in certain culture filtrates from Bacillunz anthracis by serological precipitation (Thorne & Belton, 1957) .
METHODS
Assays for factors I and I I of the anthrax tozin were described by Stanley, Sargeant & Smith (1960) .
B'resh anthrax tozin produced in vivo. This was prepared as described by Stanley et al. (1960) .
Immunizing activity. Active immunity tests were carried out in rabbits as described by Strange & Thorne (1958).
Puri;fied factors I and I I of the anthrm toxin produced in vivo. These were the final preparations described by Stanley et al. (1960) . They were kept a t -20" and examined as quickly as possible after preparation.
Puri;fied protective antigen of Strange & Thorne (1958) . We are indebted to our colleague R. E. Strange for providing freshly prepared antigen fraction C 2 which was fully satisfactory in active immunity tests in rabbits, and in agar diffusion test titrations against anthrax antisera. Fraction C 2 was kept a t -20" and examined as quickly as possible after preparation. In the assay for factor I1 activity, a solution containing 100 units antigenlml. (Strange & Thorne, 1958) had a null point dilution of l/lOO, and was therefore about 50 times as active per unit weight as was the preparation of factor I1 produced in vivo.
Puri;fied factor I from toxin produced in vitro. A culture (1 1.) containing crude antigen of Bacillus anthracis (Thorne & Belton, 1957; Strange & Thorne, 1958) was passed through a glass filter (6 cm. diameter), which was washed with O.O5~-phosphate buffer (pH 7 ; 4 x 20 ml.) a t 0". On extraction of the filter with ice cold saturated sodium carbonate solution (4 ml.), followed by neutralization of the extract with hydrochloric acid, a solution of crude factor I was obtained. This was fractionated by a modification of the method used to separate factor I produced in vivo (to be published). The purified preparation showed no evidence of heterogeneity in the ultracentrifuge at pH 7.9, or on paper electrophoresis at pH 8.6 and 5-0. Its solution ( 0 . 2 % ) had a factor I null point a t dilution 1/82,000.
Serological precipitation in gels. Unless otherwise stated, the Ouchterlony gel-diffision procedure was adopted, with the system of wells devised by Burrows & Bacon (1958) and used by Thorne & Belton (1957) . Samples (0.1 ml.) were diffused against anthrax antisera (0-1 ml.) which had been placed in the wells 24 hr. before the antigen. Diffusion was a t 0-2' in plates buffered at pH 7.3. Three antisera were used. Antiserum H . 533 was serum from a horse hyperimmunized with live spores of the 'Sterne' strain of Ban'ZZus anthracis. Since this strain produces the anthrax toxin in a serum medium (Harris-Smith et al. 1958) this antiserum should detect both factors of the anthrax toxin.
Antiserum H . 25. This was serum from a horse hyperimmunized with the crude alum-precipitate of culture filtrates from the ' Sterne ' strain of Bacillus unthracis. Since this serum was prepared from the protective filtrate it follows, from what has been said in the introduction, that it should detect factor I1 of the anthrax toxin but should not react with factor I since the latter factor is removed by filtration of the culture. On the other hand, this antiserum to the crude culture filtrate would be more likely to detect impurities of degradation products of the filtrate factor than would antiserum to live spores (antiserum H. 533).
Antiserum R-1. This was serum from a rabbit immunized with the final preparation of in vivo factor I isolated from toxic guinea-pig plasma (Stanley et d. 1960) .
RESULTS
To facilitate the description of results the antigenic factor I produced in vivo, factor I1 produced in vivo, factor I produced in vitro and the protective antigen produced in vitro (having high factor I1 activity) will be called fractions I, 11, 1 and 2, respectively. When a preparation is described as toxic this means toxic when mixed with the appropriate complementary factor. Gel-diflusion precipitation when preparations of the two toxic factors were diflwed side by side with a mixture ( M ) of fractions 11, 1 and 2 When a mixture M of fractions 11, 1 and 2 was diffused against antisera H. 588 and H. 25 the precipitation lines shown in Fig. la The four fractions, I, 11,l and 2 were then diffised adjacent to the mixture M, against each antiserum separately (see Figs. 1 b and l c ) . Although no preparation appeared to form more than one line against either antiserum it was clear that fraction I contained components A and B, in addition to a third component detected by antiserum H. 588 and giving rise to a spur in Fig. l b ; fraction I1 contained component C; fraction 1 contained component A; fraction 2 contained components €3 and C. When the four preparations were diffused adjacent to fresh anthrax toxin produced in vivo, the latter was shown to contain serological components A, B and C, among others. In view of these results of diffusion in a simple system, each preparation was examined critically for further evidence of serological heterogeneity.
Evidence that fraction I I contained a mixture of two serological components ( B and C ) On a weight basis, the factor I1 activity of fraction I1 (which was mainly guinea-pig a-globulin) was much lower than the activity of fraction 2. When more concentrated solutions of fraction I1 (c. 1000 pg./well and having factor I1 activities similar to those of the solutions of fraction 2 used for gel diffusion) were diffused on plates a second precipitation line was formed. This proved to be due to serological component B, when fraction I1 was diffused adjacent to mixture M against antiserum H. 25 (see Fig. 2a ).
E v i h e that fraction 2 contained serological componertts B and C Compa&on of fraction 2 with fraction I I by diflksion again& antiserum H . 25, 218irtg a larger antimrum well, a greater distance between the wells a d an arrangemerzt which produced a more acute angle between planes of precipitation. The two fractions 2 and I1 were compared side by side on a diffusion plate in which three wells of diameter Qmm. were arranged in the form of an equilateral triangle (distance between centres of wells 19 mm.). The amount of fraction I1 used (200 pg.) was such that lines B and C were both clearly visible. The results of difision in this system against antiserum H. 25 (Fig. 2 b ) showed that both B and C lines were present in fraction 2 (10 pg.), but the ratio of B to C was greater than in fraction 11. ( Fig. 1 c) against antiserum H. 25. The results (Fig. 2c) showed that as the amount of rabbit antiserum added to fraction 2 was increased, the two superimposed lines usually formed by fraction 2 separated, and that one was almost eliminated by the largest quantity of antiserum R-1. Appropriate controls showed that normal rabbit serum did not produce this effect; additional experiments, in which mixtures of fraction 2 and antiserum R-1 were flanked by fraction I1
at high concentration, showed that the serological component decreased in quantity and eventually removed was B and that the remaining component was C.
Progressive destruction of serological component B, but not C, by i d a t i o n with in vivo toxin. The evidence (see below) supports the other findings that fraction 2 was a mixture of components B and C. It is, however, possible that under these conditions a rapid split of fraction 2 into components B and C preceded the destruction of By or that some C was formed from B.
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Evidence that factor 11 activity was associated with serological component B and that fraction I contains this component in a non-toxic, but antigenic, form Removal of serological component B and factor 11 activity by treating fraction I 1 with an antismum (R-1) to fraction I . Serological component B was common to fractions I and 11, but serological component C was present only in fraction I1 (Fig. 1) . Reaction of fraction I1 with y-globulin from a rabbit antiserum to fraction I (R-1) removed factor I1 activity and serological component B, but left component C intact.
y-Globulin was separated from rabbit antiserum to fraction I (R-1) by the method of Deutsch (1952) and dissolved in saline a t pH 7.4. This solution was added to crude factor I1 (Stanley et al. 1960) in slight excess of the amount required to suppress serological component B (11 ml. crude factor I1 required 8 ml. y-globulin solution). This amount was determined by titration in a diffusion plate with antiserum H. 25. The crude factor I1 was then fractionated as described by Stanley et al. (1960) to obtain the product after chromatography on a diethylaminoethyl cellulose column. A mixture of crude factor I1 (11 ml.) and saline (8 ml.) was processed similarly as a control.
The dialysed and freeze-dried products obtained from the y-globulintreated and control mixtures weighed 81 and 38 mg., respectively. The treated product (9 mg.) showed no factor I1 activity, whereas the control material had a factor I1 null point a t 50 pg, When each product was titrated on a geldifision plate against antiserum H. 25, serological component B was detected in the treated product (8 mg.) although it was still precipitable from the control (0.5 mg.); in both cases the C line was still detectable a t 60 pg.
It was important to be sure that the absence of factor I1 activity from the treated sample was not due to the presence of antibody to factor I (since antiserum R-1 was produced against fraction I) which neutralized the factor I used in the assay of factor 11. For this reason the immune y-globulin was added to crude factor 11, because the subsequent fractionation of factor I1 was known to remove excess y-globulin. The absence of antibody to factor I from the final product was tested by including it in a toxic mixture containing an excess of factor 11, i.e. a mixture the toxicity of which was limited by its factor I content. The size of the skin reaction was the same as that produced by the toxic mixture alone, Preferential destruction of serological component B and factor 11 activity in fraction 2 by i&ation with toxin produced in vivo. Crude toxin produced in vivo contained a system which destroyed factor I1 activity a t 37O. The serological precipitation of a mixture of fraction 2 and this toxin was studied after incubation. A solution consisting of fraction 2 (1 ml., factor I1 null point 1/640) toxin produced in vivo (1 ml., null point 1/80) and O.O5~-tris buffer (pH 8; 8 ml.), had a factor I1 null point of 1/128. A sample was kept a t -20' and the remainder incubated a t 87'. Samples removed at 3, 8, 24 and 48 hr. had factor I1 null points of 11128, 1/64, l/S and 111, respectively. The results obtained on precipitation of these samples (undiluted) in plates with antiserum H. 25 are shown in Fig. 3 . The usual composite line was present initially and when titrated was just visible at a dilution of 1/64. After 8 and 8 hr. two lines were seen, both of which joined smoothly into the line formed by the original sample. With the mixture M (see above) as a control, the line nearer the antigen wall (when titrated, just visible at 1/32 of both samples) was shown to be the B line, and that nearer the antiserum well was shown to be the C line (also just visible at 1/82 of both samples). After 24 hr. the B line was much weaker (just visible at 1/2) and after 48 hr. it could not be detected with antiserum H. 25; but the C line was still present in unchanged intensity (just visible at 1/82). Antiserum H. 588 formed one line (the B line) with the original sample (just visible at a dilution of 1/128). After the sample had been incubated for 48 hr. at 87' this line was not detectable at a dilution higher than 112. In a control experiment the toxin produced in vivo, at the concentration used in the original mixture, did not give a line with either antiserum. Active immunity tests, by the procedure of Strange & Thorne (1958), on the original mixture and on the product after heating for 48 hr., showed that a considerable degree of protective activity survived this treatment, Table 1 shows the results of these immunity tests compared with the factor I1 activities and serological precipitation data for the two samples. Examination of fraction 1 for the presence of mure thun one serologkal cornp0mm.t In the short diffision system fkaction 1 ( 5 pg.) formed a single line (A) with antiserum H. 588 and this line did not appear to be composite when fraction 1 was flanked by a mixture of fractions 11, 2 and 1 (Fig. 1b) or by fraction I. When allowed to diffise over a greater distance (10 mm.) fraction 1 (10 pug.) still did not form more than one line. This amount of fraction 1 did not form precipitation lines with antiserum H. 25. However, when SO pg. of fraction 1 were placed in the short diffusion system a faint second line was formed against antiserum H. 533 and two faint lines were formed against antiserum H. 25. These additional lines were probably not associated with factor I activity since they were also formed by far s d e r amounts of some relatively inactive fractions discarded during the purification of factor I. * The dilution quoted in each case is the greatest at which a line was still formed.
-f After heating for 1 hr., the lines were sufficiently apart to see individual titrations. $ The test was carried out as described by Strange & Thorne (1958) .
DISCUSSION
A serological comparison on gel-diffusion plates of the-purified preparations of factors I and I1 of the anthrax toxin obtained in vitro and in vivo indicated that all but one of these contained at least two major serological components. Not less than three serological entities, designated A, B and C, were involved in the total system. Component A appeared to be associated with factor I activity. Component B appeared to be associated with factor I1 activity, although it was present in one preparation having no factor I1 activity. Component C did not appear to be associated with toxic activity. Components A and B were precipitated well and component C only weakly by an anthrax antiserum against live spores (antiserum H. 588). Components B and C were precipitated well and component A not a t all by an anthrax antiserum against crude antigen produced in vitro (Belton & Strange, 1954) . The behaviour of the various preparations was as follows.
(1) The purified preparation of factor I produced in witro contained the single major serological component A.
(2) The purified preparation of the protective antigen produced in vitro (Strange & Thorne 1958) contained a mixture of serological component B, associated with factor I1 activity, and the non-toxic component C. These components appeared to be present in such concentrations that the two precipitation lines were superimposed. This preparation did not contain component A and the apparent connexion between in wiwo factor I and the purified antigen (Smith, 1958) was due to the presence in each of component B (see below).
( 8 ) The purified preparation of factor I produced in Viwo (Stanley et al. 1960) contained, in addition to serological component A (associated with factor I activity), some component B despite the fact that it had no factor I1 activity. Since our antiserum to this preparation neutralized factor I1 activity, it was possible that component B was here present in a non-toxic but antigenic form. In addition to components A and B this preparation also contained another serological component which was not present in the other three preparations.
(4) The partially purified preparation of factor I1 produced in vivo (Stanley et al. 1960 ) contained a mixture of serological components B (associated with factor I1 activity) and the non-toxic component C, as well as much guineapig a-globulin. The proportion of component B to component C was less than that in the preparation from the culture in witro.
It is possible that one or more of the various preparations which appeared to contain mixtures of antigens contained only single antigens and that evidence for two or more serological components was due to decomposition during the diffusion and precipitation. We believe this to be unlikely, however, in view of the low temperature and neutral pH values at which ah kperiments were carried out. At the moment it is impossible to estimate the proportions of the three serological components in these mixtures, since the relationship between weight and ability to produce precipitation lines is &own, at least for components B and C.
It is clear from these results that the method of measuring immunogenicity in certain culture filtrates described by Thorne & Belton (1957) is not genelrally applicable to all products of BtzciZZzcs anthrds. In our experiments, b e titres of test preparations against 'spore' antiserum (H. 538) and 'antigen' antiserum (H. 25) did not agree with one another, or with the results of active immunity tests. Furthermore, as a criterion of serological purity, the production of a single precipitation line after diffusion alone in the simple system described by Thorne & Belton (1957) should be supplemented by experiments in which diffusion takes place from wells adjacent to those containing likely impurities, and possibly over a greater distance, in an arrangement of wells which will produce a more acute angle between planes of precipitation.
We are indebted to our colleague Mr F. C. Belton for the horse anthrax antisera and the cultures of Bacillw anthr&.
